SAN JOSE, CA, VitalConnect has announced the closing on an oversubscribed Series F financing in excess of $30 million.
The financing round was led by Revelation Partners with significant participation from the company's existing investors, including Pacific General Ventures and EW Healthcare Partners. The additional funding will support VitalConnect's rapidly growing remote cardiac monitoring business while advancing key partnerships with the largest hospital systems in the United States to provide remote patient monitoring in an in-patient setting.
VitalConnect is a leader in wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations. VitalConnect leverages extensive expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms that achieve better health and economic outcomes. VitalConnect's products are designed for use in a broad range of inpatient and outpatient settings, such as hospital monitoring, post-discharge care, cardiac monitoring and pharmaceutical solutions. VitalConnect's advanced, yet easy-to-use, platform, was designed to deliver better healthcare at lower costs while providing more convenience for the patients and healthcare providers.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about